TABLE 2.
Engineering strategies | Bioproducts | Strategy details | References |
Constructing and engineering metabolic pathways | EPA | Constructing synthetic pathways | Xue et al., 2013 |
Lipids | Improving acetyl-CoA supplement | Xu et al., 2016 | |
Lipids | Increasing NADPH availability | Qiao et al., 2017 | |
Trans-10, cis-12 CLA | Overexpressing the endogenous enzymes | Wang et al., 2019 | |
Fatty alcohols | Eliminating downstream degradation | Rutter and Rao, 2016 | |
Optimizing fermentation conditions | γ-decalactone | Improving oxygen transfer | Moradi et al., 2013 |
GLA | A temperature-shift strategy of cultivation | Sun et al., 2017 | |
CLA | Changing the medium components | Wang et al., 2019 | |
EPA | Two-stage continuous fermentation | Xie et al., 2017 | |
Engineering compartmentalization system | FAEE | Endoplasmic reticulum or peroxisome localization | Xu et al., 2016 |
Alkane | Endoplasmic reticulum or peroxisome localization | ||
Fatty alcohol | Peroxisome localization | ||
γ-decalactone | Cell immobilization | Zhang et al., 2020 |